Case Study Highlights Tardive Dyskinesia and the Importance of Early Diagnosis and Treatment
Researchers of a study assessed tardive dyskinesia (TD). TD is primarily caused by medication use, particularly neuroleptic drugs, and can affect approximately 2% to 5% of patients annually.
Study Reveals Sex Differences in Cognitive Impairment Among Schizophrenia Patients With Tardive Dyskinesia
A recent study examined potential sex differences in cognitive performance among schizophrenia patients with tardive dyskinesia (TD).
Managing Tardive Dyskinesia: Alleviating Symptoms and Gaining Control Through Stress Reduction
Researchers of a recent study examined tardive dyskinesia (TD) and strategies individuals with TD can utilize to help reduce stress and maximize their ability to control their movements.
Exploring Tardive Dyskinesia Diagnostic and Treatment Fundamentals
Researchers of a recent study explored the diagnostic and treatment fundamentals of tardive dyskinesia (TD), a condition characterized by involuntary movements in various parts of the body, such as the tongue, lips, face, trunk, and extremities
Understanding and Managing Extrapyramidal Effects Caused by Antipsychotic Medications
Researchers of a study explored the pathophysiology of extrapyramidal effects (EPS) caused by antipsychotic medications, including the delicate balance between therapeutic effects and extrapyramidal effects.
Consensus Input on Assessing the Impact of Tardive Dyskinesia
An advisory panel developed consensus recommendations on the assessment of the functional impact of tardive dyskinesia in clinical settings.
Treatment Recommendations
Using the American Academy of Neurology Risk of Bias Classification system and Scottish Intercollegiate Guidelines Network framework, researchers performed a systematic review of studies on the treatment of tardive dyskinesia and provide treatment recommendations.
American Academy of Neurology
An evidence-based guideline from the American Academy of Neurology provides treatment recommendations for tardive syndromes, as well as a treatment algorithm.
American Psychiatric Association Practice Guideline
Presented in a standardized format, the American Psychiatric Association practice guidelines provide evidence-based recommendations for the assessment and treatment of psychiatric disorders.
Development of the Impact-TD Scale to Evaluate the Impact of Tardive Dyskinesia
A consensus panel aimed to develop the Impact-TD scale to evaluate the effect of TD on the daily functioning of patients in the practice setting. The panel included seven people who had been on a prior panel who established recommendations on the importance of ideal evaluation of the functional effect of TD. The panel prior had also developed a narrative literature review summarizing present methods in evaluating the effect of TD both in clinical research and practice. In the development of the Impact-TD scale, the panel deliberated its main elements to be able to explain the detailed impact of TD symptoms where there may be difficulty to patients. The panel came up with four functional domains being social, psychological/psychiatric, physical, and vocational/educational/recreational.
